Company
Headquarters: Shanghai, China
Employees: 1,308
CEO: Dr. Xiucai Liu
CN¥33.99 Billion
CNY as of July 1, 2025
US$4.75 Billion
Company | Market Cap (USD) |
---|---|
Air Liquide SA | $121.83 B |
Air Products and Chemicals, Inc. | $64.60 B |
Shin-Etsu Chemical Co Ltd | $62.74 B |
BASF SE | $46.38 B |
Saudi Basic Industries Corp | $44.80 B |
Company | Market Cap (USD) |
---|---|
Linde | $224.62 B |
BHP | $151.21 B |
Air Liquide SA | $121.83 B |
Rio Tinto | $95.24 B |
The Sherwin-Williams Company | $88.71 B |
Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company is headquartered in Shanghai, China.
Last Financial Reports Date | March 31, 2025 |
Revenue TTM | CN¥3.05 B |
EBITDA | CN¥693.6 M |
Gross Profit TTM | CN¥901.0 M |
Profit Margin | 17.08% |
Operating Margin | 18.45% |
Quarterly Revenue Growth | 13.30% |
Cathay Biotech, Inc. has the following listings and related stock indices.
Stock: SSE: 688065 wb_incandescent